An Exceptional Broad-Spectrum Nanobiocide for Multimodal and Synergistic Inactivation of Drug-Resistant Bacteria

被引:29
|
作者
Xue, Ke [1 ]
Yang, Cuihong [2 ]
Wang, Chun [1 ]
Liu, Yang [1 ]
Liu, Jianfeng [2 ]
Shi, Linqi [1 ]
Zhu, Chunlei [1 ]
机构
[1] Nankai Univ, Coll Chem, Inst Polymer Chem, Key Lab Funct Polymer Mat,Minist Educ,State Key L, Tianjin 300071, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin 300192, Peoples R China
来源
CCS CHEMISTRY | 2022年 / 4卷 / 01期
基金
中国国家自然科学基金;
关键词
nanobiocides; photothermal materials; in situ surface polymerization; drug-resistant bacteria; multimodal and synergistic therapy; FATTY-ACIDS; NANOPARTICLES; NANOMATERIALS; THERAPY;
D O I
10.31635/ccschem.021.202000714
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This study reports the fabrication of a novel photothermal material formed via the physical blending of excess lauric acid (LA) and cupric acetate, followed by efficient ligand exchange. Surprisingly, the copper-LA complex exhibited a 12-fold enhancement of the molar extinction coefficient in the near-infrared (NIR) region relative to aqueous cupric acetate. Inspired by this interesting finding, we formulated these photothermal materials into colloidally dispersed nanoparticles via a technique that combined nanoprecipitation and in situ surface polymerization for antibacterial studies. The resultant nanoparticles exhibited rapid and stable photothermal responses to NIR irradiation, with a 4-fold enhanced photothermal conversion efficiency relative to aqueous cupric acetate. Since a positively charged monomer was incorporated during in situ surface polymerization, these positively charged nanoparticles were ingested efficiently and subsequently digested by drug-resistant bacteria. By combining the LA-mediated membrane-damaging effect, copper-mediated Fenton-like reaction, as well as the photothermal effect of the copper-LA complex, a broad-spectrum, multimodal, and synergistic antibacterial effect was achieved both in vitro and in vivo, with the killing efficiency up to 99.99% for ampicillin-resistant Escherichia coli (Amp' E. coli) and 99.9999% for methicillin-resistant Staphylococcus aureus (MRSA). Our newly developed nanobiocide represents a class of exceptional broad-spectrum antibacterial materials, holding great potential for treating drug-resistant infections in clinical settings. [GRAPHICS] .
引用
收藏
页码:272 / 285
页数:14
相关论文
共 50 条
  • [1] An Exceptional Broad-Spectrum Nanobiocide for Multimodal and Synergistic Inactivation of Drug-Resistant Bacteria (vol 4, pg 272, 2022)
    不详
    CCS CHEMISTRY, 2022, 4 (01): : 390 - 390
  • [2] Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria
    Surendran, Amrutha
    Turnbull, Agnes
    Flockhart, Allen
    Findlay-Greene, Fern
    Nowosielska, Martyna
    Morrison, Donald
    Mincher, David J.
    Donnellan, Samantha
    ALL LIFE, 2024, 17 (01)
  • [3] Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria
    Charrier, Cedric
    Salisbury, Anne-Marie
    Savage, Victoria J.
    Duffy, Thomas
    Moyo, Emmanuel
    Chaffer-Malam, Nathan
    Ooi, Nicola
    Newman, Rebecca
    Cheung, Jonathan
    Metzger, Richard
    McGarry, David
    Pichowicz, Mark
    Sigerson, Ralph
    Cooper, Ian R.
    Nelson, Gary
    Butler, Hayley S.
    Craighead, Mark
    Ratcliffe, Andrew J.
    Best, Stuart A.
    Stokes, Neil R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)
  • [4] Combating infections from drug-resistant bacteria: Unleashing synergistic broad-spectrum antibacterial power with high-entropy MXene/CDs
    Wang, Panyong
    You, Qiannan
    Liu, Yulu
    Miao, Huimin
    Dong, Wen-Fei
    Li, Li
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2024, 238
  • [5] Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites
    Kevin, Dion A., II
    Meujo, Damaris A. F.
    Hamann, Mark T.
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (02) : 109 - 146
  • [6] Rediscovery of Tetronomycin as a Broad-Spectrum and Potent Antibiotic against Drug-Resistant Gram-Positive Bacteria
    Kimishima, Aoi
    Tsuruoka, Iori
    Kanto, Hiroki
    Tsutsumi, Hayama
    Arima, Naoaki
    Sakai, Kazunari
    Sugamata, Miho
    Matsui, Hidehito
    Watanabe, Yoshihiro
    Iwatsuki, Masato
    Honsho, Masako
    Naher, Kamrun
    Inahashi, Yuki
    Hanaki, Hideaki
    Asami, Yukihiro
    ACS OMEGA, 2023, 8 (12): : 11556 - 11563
  • [7] Analysis of the broad-spectrum potential of nitric oxide for antibacterial activity against clinically isolated drug-resistant bacteria
    Bright, Lori M. Estes
    Chug, Manjyot Kaur
    Thompson, Stephen
    Brooks, Megan
    Brisbois, Elizabeth J.
    Handa, Hitesh
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2024, 112 (07)
  • [8] Degradable Carbon Dots from Cigarette Smoking with Broad-Spectrum Antimicrobial Activities against Drug-Resistant Bacteria
    Song, Yuxiang
    Lu, Fang
    Li, Hao
    Wang, Huibo
    Zhang, Mangling
    Liu, Yang
    Kang, Zhenhui
    ACS APPLIED BIO MATERIALS, 2018, 1 (06) : 1871 - 1879
  • [9] A new tetronomycin analog, broad-spectrum and potent antibiotic against drug-resistant Gram-positive bacteria
    Kimishima, Aoi
    Tsuruoka, Iori
    Tsutsumi, Hayama
    Honsho, Masako
    Honma, Sota
    Matsui, Hidehito
    Sugamata, Miho
    Wasuwanich, Paul
    Inahashi, Yuki
    Hanaki, Hideaki
    Asami, Yukihiro
    CHEMISTRY & BIODIVERSITY, 2024, 21 (02)
  • [10] Elaborately engineered Au(I)-based AIEgens: Robust and broad-spectrum elimination abilities toward drug-resistant bacteria
    Deng, Shuangling
    Peng, Zhen
    Zhou, Fang
    Zhong, Guanqing
    Cai, Zhen
    Tang, Xiaodong
    Xu, Changhuo
    Zheng, Lei
    Tang, Ben Zhong
    Zhang, Jing
    AGGREGATE, 2024, 5 (05):